These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8557271)

  • 1. Apparent higher frequency of phenylketonuria in the Mexican state of Jalisco.
    Velázquez A; Bilbao G; González-Trujillo JL; Hernández D; Pérez-Andrade ME; Vela M; Cicerón I; Loera-Luna A; Cederbaum S; Phoenix B
    Hum Genet; 1996 Jan; 97(1):99-102. PubMed ID: 8557271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of classical phenylketonuria in mentally retarded individuals in Iran.
    Ghiasvand NM; Aledavood A; Ghiasvand R; Seyedin Borojeny F; Aledavood AR; Seyed S; Miner W; Saeb Taheri GR
    J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S283-7. PubMed ID: 19768570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence of phenylketonuria in Thailand.
    Kietduriyakul V; Komkris V; Tongkittikul K; Leangphibul P
    J Med Assoc Thai; 1989 Sep; 72(9):516-9. PubMed ID: 2809457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of phenylketonuria and some other metabolic disorders among mentally retarded patients in Finland.
    Palo J
    Acta Neurol Scand; 1967; 43(5):573-9. PubMed ID: 6083364
    [No Abstract]   [Full Text] [Related]  

  • 5. Causes of delay in referral of patients with phenylketonuria to a specialized reference centre in Mexico.
    Vela-Amieva M; Ibarra-González I; Fernández-Lainez C; Monroy-Santoyo S; Guillén-López S; Belmont-Martínez L; Hernández-Montiel A
    J Med Screen; 2011; 18(3):115-20. PubMed ID: 22045819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neonatal screening for congenital hypothyroidism and phenylketonuria].
    Velázquez A; Loera-Luna A; Aguirre BE; Gamboa S; Vargas H; Robles C
    Salud Publica Mex; 1994; 36(3):249-56. PubMed ID: 7940004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment and control of patients with phenylketonuria: results from the Collaborative Group of Spanish Follow-up Units].
    Campistol J; González MJ; Gutiérrez AP; Vilaseca MA;
    Med Clin (Barc); 2012 Mar; 138(5):185-91. PubMed ID: 21794880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenylketonuria is still a major cause of mental retardation in Tunisia despite the possibility of treatment.
    Khemir S; El Asmi M; Sanhaji H; Feki M; Jemaa R; Tebib N; Dhondt JL; Ben Dridi MF; Mebazaa A; Kaabachi N
    Clin Neurol Neurosurg; 2011 Nov; 113(9):727-30. PubMed ID: 21862209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of inborn errors of metabolism.
    Velázquez A; Vela-Amieva M; Cicerón-Arellano I; Ibarra-González I; Pérez-Andrade ME; Olivares-Sandoval Z; Jiménez-Sánchez G
    Arch Med Res; 2000; 31(2):145-50. PubMed ID: 10880718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenylketonuria among the mentally retarded in India.
    Centerwall WR; Ittyerah TR
    Lancet; 1966 Jul; 2(7456):193-4. PubMed ID: 4161163
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of the phenylketonuria screening programme in Estonia.
    Ounap K; Lilleväli H; Metspalu A; Lipping-Sitska M
    J Med Screen; 1998; 5(1):22-3. PubMed ID: 9575455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Institutes of Health Consensus Development Conference Statement: phenylketonuria: screening and management, October 16-18, 2000.
    National Institutes of Health Consensus Development Panel
    Pediatrics; 2001 Oct; 108(4):972-82. PubMed ID: 11581453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of phenylketonuria in British Columbia, 1950-1971.
    Lowry RB; Tischler B; Cockcroft WH; Renwick DH
    Can Med Assoc J; 1972 Jun; 106(12):1299-302. PubMed ID: 5035136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PKU screening-is it worth it?
    The Advisory Committee on Inborn Errors of Metabolism to the Ministry of Health
    Can Med Assoc J; 1973 Feb; 108(3):328-9. PubMed ID: 4691095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenylketonuria incidence in China between 2013 and 2017 based on data from the Chinese newborn screening information system: a descriptive study.
    Xiang L; Tao J; Deng K; Li X; Li Q; Yuan X; Liang J; Yu E; Wang M; Wang H; Liu H; Zhu J
    BMJ Open; 2019 Aug; 9(8):e031474. PubMed ID: 31444193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A survey for the incidence of phenylketonuria in Guangdong, China.
    Jiang J; Ma X; Huang X; Pei X; Liu H; Tan Z; Zhu L
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():185. PubMed ID: 15906732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of phenylketonuria in Norway.
    Saugstad LF
    Clin Genet; 1975 Jan; 7(1):40-51. PubMed ID: 1116309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of phenylketonuria by the newborn screening program in Thailand.
    Pangkanon S; Charoensiriwatana W; Janejai N; Boonwanich W; Chaisomchit S
    Southeast Asian J Trop Med Public Health; 2009 May; 40(3):525-9. PubMed ID: 19842439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical screening for inherited metabolic disorders in the mentally retarded.
    Henderson HE; Goodman R; Schram J; Diamond E; Daneel A
    S Afr Med J; 1981 Nov; 60(19):731-3. PubMed ID: 6795726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenylketonuria (PKU): screening and management.
    NIH Consens Statement; 2000 Oct 16-18; 17(3):1-33. PubMed ID: 11757784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.